Guided Therapeutics BPA Q/Q
Quel est le BPA Q/Q de Guided Therapeutics?
Le BPA Q/Q de Guided Therapeutics, Inc. est N/A
Quelle est la définition de BPA Q/Q?
Le taux de croissance du BPA trimestriel, d’un trimestre à l’autre , correspond à l’augmentation du BPA d’une entreprise au cours des 4 derniers trimestres par rapport à la performance des 4 trimestres précédents.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Que fait Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.